CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 206 enrolled
Drug / intervention
Robotic-Assisted Surgery (RAS) Hernia Repair Surgerydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06445504
NCT06445504N/AActive
CompareCT.gov

A Prospective, Multi-center, Single-arm Study of the Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Inguinal and Ventral Hernia Repair Surgery (Enable Hernia Repair)

Medtronic - MITG·interventional·Posted Jun 6, 2024·Updated May 4, 2026

In Brief

A clinical study evaluating Robotic-Assisted Surgery (RAS) Hernia Repair Surgery for Inguinal Hernia and Ventral Hernia. Active but no longer recruiting, targeting 206 participants across 7 sites.

Detailed Summary

A prospective, multicenter, single-arm pivotal study will be performed with 192 subjects enrolled to have an inguinal or ventral robotic hernia repair procedure using the Medtronic Hugo™ RAS system. Subjects will be followed through two years. This study will be conducted using up to ten investigative sites in the United States (US).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInguinal Hernia, Ventral Hernia
CountriesUnited States
Collaborators--

Timeline

N/AActive
202520262027
First PostedJun 6, 2024
Enrollment StartApr 8, 2024
Primary CompletionMar 19, 2025
Study CompletionMar 1, 2027
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 2.1 years ago

Interventions

Robotic-Assisted Surgery (RAS) Hernia Repair Surgerydevice

Patients indicated for Robotic-Assisted Surgery (RAS) for ventral and inguinal hernia repair will have the RAS surgery using the Medtronic Hugo RAS system